New hope for kids with hodgkin lymphoma: shorter treatment trial shows promise
NCT ID NCT00846742
Summary
This study is testing whether a shorter, 8-week chemotherapy regimen works as well as longer treatments for children with favorable-risk Hodgkin lymphoma. Some patients who still show cancer after chemotherapy also receive targeted, low-dose radiation. The goal is to effectively control the cancer while potentially reducing the overall treatment burden and side effects for young patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Illinois at OSF St. Francis Medical Center
Peoria, Illinois, 61637, United States
-
Dana-Farber Harvard Cancer Center
Boston, Massachusetts, 02115, United States
-
Maine Children's Cancer Program (MCCP)
Scarborough, Maine, 04074, United States
-
Packard Children's Hospital, Stanford University
Palo Alto, California, 94304, United States
-
Rady Children's Hospital- San Diego
San Diego, California, 92123, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.